Glycocholic acid

CAS No. 475-31-0

Glycocholic acid( Cholylglycine )

Catalog No. M14581 CAS No. 475-31-0

Glycocholic acid, or cholylglycine, is a crystalline bile acid involved in the emulsification of fats. It occurs as a sodium salt in the bile of mammals.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 45 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Glycocholic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Glycocholic acid, or cholylglycine, is a crystalline bile acid involved in the emulsification of fats. It occurs as a sodium salt in the bile of mammals.
  • Description
    Glycocholic acid, or cholylglycine, is a crystalline bile acid involved in the emulsification of fats. It occurs as a sodium salt in the bile of mammals. It is a conjugate of cholic acid with glycine. Its anion is called glycocholate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cholylglycine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    475-31-0
  • Formula Weight
    465.64
  • Molecular Formula
    C26H43NO6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: Soluble
  • SMILES
    C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang A, et al. Clin Chim Acta. 2013 Mar 15;418:86-90.
molnova catalog
related products
  • PHGDH-inactive

    PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .

  • Ganoderic acid DM

    Ganoderic acid DM is an antiandrogenic osteoclastogenesis inhibitor, it especially suppresses the expression of c-Fos and nuclear factor of activated T cells c1 (NFATc1).

  • Ciamexon

    Ciamexon (Ciamexone) is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.